Aridis Pharmaceuticals - 48 Year Dividend Yield History | ARDS

Historical dividend payout and yield for Aridis Pharmaceuticals (ARDS) since 1971. The current TTM dividend payout for Aridis Pharmaceuticals (ARDS) as of February 22, 2019 is $0.00. The current dividend yield for Aridis Pharmaceuticals as of February 22, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.066B $0.000B
Aridis Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the discovery and development of immunotherapy using fully human monoclonal antibodies to treat life-threatening infections. The company's product pipeline consists of AR-301, AR-105, AR-101, AR-401, AR-201 and AR-501 which are in clinical stages. Aridis Pharmaceuticals, Inc. is based in San Jose, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.316B 12.97
Gilead Sciences (GILD) United States $86.647B 10.87
Bio-Techne Corp (TECH) United States $7.316B 49.29